Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
11.94
+0.08 (0.67%)
At close: Jun 12, 2026, 4:00 PM EDT
11.88
-0.06 (-0.50%)
After-hours: Jun 12, 2026, 4:10 PM EDT
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $446.39 million as of June 12, 2026. Its market cap has increased by 383.31% in one year.
Market Cap
446.39M
Enterprise Value
204.78M
1-Year Change
383.31%
Ranking
Category
Stock Price
$11.94
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $446.39M, an increase of 11.02%. That is a compound annual growth rate of 4.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 446.39M | 6.91% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 476.37M |
| 4D Molecular Therapeutics | 461.86M |
| Eikon Therapeutics | 459.64M |
| Neurogene | 458.26M |
| Arvinas | 457.46M |
| Assembly Biosciences | 445.10M |
| Sutro Biopharma | 438.79M |
| Prothena Corporation | 432.44M |